Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test ...
VENLO, The Netherlands, February 04, 2025--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court (Bundespatentgericht) has ...
Table 1. Baseline demographic and clinic characteristics of 373 HIV-infected patients undergoing tuberculin skin test, QuantiFERON-TB Gold and T-SPOT-TB testing, stratified according to past or ...